Postmenopausal Osteoporosis Therapeutics Market - Persistence Market Research

Postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market.

绝经后骨质疏松症，随着全球人口老龄化趋势的加剧，已成为提升绝经后骨质疏松症发病率的主要因素。该病症的普遍性上升及相应药物市场的创新，是推动绝经后骨质疏松症治疗市场增长的主要动力。